Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
Balar, A.V., Castellano, D.E., Grivas, P., Vaughn, D.J., Powles, T., Vuky, J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Necchi, A., Petrylak, D.P., Plimack, E.R., Xu, J.Z., Imai, K., Moreno, B.H., Bellmunt, J., de Wit, R., O’Donnell, P.H.
Published in Annals of oncology (01.03.2023)
Published in Annals of oncology (01.03.2023)
Get full text
Journal Article
Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)–tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma
Nadal, R., Amin, A., Geynisman, D.M., Voss, M.H., Weinstock, M., Doyle, J., Zhang, Z., Viudez, A., Plimack, E.R., McDermott, D.F., Motzer, R., Rini, B., Hammers, H.J.
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations
Plimack, E. R., Desai, J. R., Issa, J. P., Jelinek, J., Sharma, P., Vence, L. M., Bassett, R. L., Ilagan, J. L., Papadopoulos, N. E., Hwu, W. J.
Published in Investigational new drugs (01.10.2014)
Published in Investigational new drugs (01.10.2014)
Get full text
Journal Article
501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial
George, S, Motzer, R.J, Hammers, H, Redman, B, Kuzel, T, Tykodi, S.S, Plimack, E, Jiang, J, Waxman, I, Rini, B.I
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
A phase I study of decitabine with pegylated interferon alpha -2b in advanced melanoma: impact on DNA methylation and lymphocyte populations
Plimack, E R, Desai, J R, Issa, J P, Jelinek, J, Sharma, P, Vence, L M, Bassett, R L, Ilagan, J L, Papadopoulos, N E, Hwu, W J
Published in Investigational new drugs (01.10.2014)
Published in Investigational new drugs (01.10.2014)
Get full text
Journal Article
Improved Outcomes in Men Treated With Adjuvant or Early Salvage Postprostatectomy IMRT or 3DCRT at a Single Institution
Murphy, C, Uzzo, R.G, Ruth, K.J, Viterbo, R, Plimack, E, Buyyounouski, M.K, Kutikov, A, Chen, D.Y.T, Greenberg, R.E, Horwitz, E.M
Published in International journal of radiation oncology, biology, physics (01.10.2013)
Published in International journal of radiation oncology, biology, physics (01.10.2013)
Get full text
Journal Article
Inflammatory Bowel Disease Is Not an Absolute Contraindication to Definitive Radiation Therapy for Prostate Cancer
Murphy, C, Ruth, K.J, Buyyounouski, M.K, Heller, S, Weinberg, D, Uzzo, R, Plimack, E, Kutikov, A, Chen, D.Y.T, Horwitz, E.M
Published in International journal of radiation oncology, biology, physics (01.10.2013)
Published in International journal of radiation oncology, biology, physics (01.10.2013)
Get full text
Journal Article
Identification of Groups at Increased Risk of Prostate Cancer (PCa) Death After Salvage Radiation Therapy (sRT) Using Recursive Partitioning Analysis (RPA): Results From an NCI-Designated Comprehensive Cancer Center
Murphy, C, Ruth, K, Martin, J, Uzzo, R, Chen, D, Wong, Y, Sobczak, M, Hayes, S, Hallman, M, Rosalia, V, Kutikov, A, Smaldone, M, Greenberg, R, Plimack, E, Horwitz, E
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Get full text
Journal Article
522 NEOADJUVANT ACCELERATED MVAC IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER: A MULTI-INSTITUTIONAL PROSPECTIVELY ACCRUED COHORT
Mehrazin, Reza, Plimack, E, Kutikov, A, Tomaszewski, J, Hoffman-Censits, J, Viterbo, R, Greenberg, R, Ginzburg, S, Corcoran, A, Lallas, C, Trabulsi, E, Wong, Y-N, Boorjian, S, Smaldone, M, Uzzo, R, Chen, D
Published in The Journal of urology (01.04.2013)
Published in The Journal of urology (01.04.2013)
Get full text
Journal Article
989TiPKEYNOTE-905: A phase III study of cystectomy plus perioperative pembrolizumab versus cystectomy alone in cisplatin (cis)-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC)
Galsky, M, Necchi, A, Shore, N D, Witjes, F, Nam, K, Godwin, J L, Frenkl, T L, Plimack, E R
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
Tannir, N.M., Albigès, L., McDermott, D.F., Burotto, M., Choueiri, T.K., Hammers, H.J., Barthélémy, P., Plimack, E.R., Porta, C., George, S., Donskov, F., Atkins, M.B., Gurney, H., Kollmannsberger, C.K., Grimm, M.-O., Barrios, C., Tomita, Y., Castellano, D., Grünwald, V., Rini, B.I., Jiang, R., Desilva, H., Fedorov, V., Lee, C.-W., Motzer, R.J.
Published in Annals of oncology (02.08.2024)
Published in Annals of oncology (02.08.2024)
Get full text
Journal Article
Pembrolizumab produces clinically meaningful responses as first-line therapy in cisplatin-ineligible advanced urothelial cancer: Results from subgroup analyses of KEYNOTE-052
Powles, T, Bellmunt, J, Castellano, D, O’Donnell, P, Grivas, P, Vuky, J, Plimack, E, Hahn, N, Balar, A, Pang, L, Savage, M, Perini, R, Keefe, S, Bajorin, D, De Wit, R
Published in European urology supplements : official journal of the European Association of Urology (01.03.2017)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2017)
Get full text
Journal Article
Axitinib in combination with pembrolizumab in patients (pts) with advanced renal cell carcinoma (aRCC): Preliminary safety and efficacy results
Atkins, M.B., Plimack, E.R., Puzanov, I., Fishman, M.N., McDermott, D., Cho, D.C., Vaishampayan, U., George, S., Olencki, T., Tarazi, J., Rosbrook, B., Fernandez, K., Keefe, S., Choueiri, T.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Pembrolizumab (pembro) as first-line therapy for advanced/unresectable or metastatic urothelial cancer: Preliminary results from the phase 2 KEYNOTE-052 study
Balar, A., Bellmunt, J., O'Donnell, P.H., Castellano, D., Grivas, P., Vuky, J., Powles, T., Plimack, E.R., Hahn, N.M., de Wit, R., Pang, L., Savage, M.J., Perini, R., Keefe, S., Bajorin, D.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
911PDA first-in-human phase I/II trial of the oral HIF-2a inhibitor PT2977 in patients with advanced RCC
Jonasch, E, Plimack, E R, Bauer, T, Merchan, J R, Papadopoulos, K P, McDermott, D F, Michaelson, M D, Appleman, L J, Thamake, S, Zojwalla, N, Choueiri, T K
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Perioperative pembrolizumab or pembrolizumab + enfortumab vedotin and cystectomy versus cystectomy alone in cisplatin-ineligible patients with muscle-invasive bladder cancer: Phase 3 KEYNOTE-905/EV-303 study
Necchi, A., Galsky, M.D., Shore, N.D., Plimack, E., Jia, C., Homet Moreno, B., Witjes, J.A.
Published in European urology open science (Online) (01.11.2021)
Published in European urology open science (Online) (01.11.2021)
Get full text
Journal Article
Exome sequencing of tumor samples from S1107 “Randomized phase II evaluation of tivantinib and tivantinib in combination with erlotinib in patients with papillary renal cell carcinoma (pRCC)”
Twardowski, P., Wu, X., Plets, M., Tangen, C., Plimack, E., Agarwal, N., Vogelzang, N.J., Wang, J., Tao, S., Thomson, I., Lara, P.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Efficacy and safety of nivolumab monotherapy in patients with metastatic urothelial cancer (mUC) who have received prior treatment: Results from the phase II CheckMate 275 study
Galsky, M.D., Retz, M., Siefker-Radtke, A.O., Baron, A., Necchi, A., Bedke, J., Plimack, E.R., Vaena, D., Grimm, M.-O., Bracarda, S., Arija, J. Arranz, Pal, S.K., Ohyama, C., Saci, A., Lambert, A., Krishnan, S., Azrilevich, A., Sharma, P.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Outcomes of patients with metastatic urothelial carcinoma (mUC) with exclusive bone metastases: Focus on a special patient population
Necchi, A., Pond, G.R., Pal, S.K., Agarwal, N., Bowles, D., Plimack, E., Yu, E.Y., Ladoire, S., Baniel, J., Crabb, S., Niegisch, G., Golshayan, A.R., Sridhar, S., Berthold, D., Rosenberg, J.E., Powles, T., Bamias, A., Harshman, L.C., Bellmunt, J., Galsky, M.D.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Pembrolizumab (pembro) as first-line therapy in cisplatin-ineligible advanced urothelial cancer (UC): Outcomes from KEYNOTE-052 in senior patients (pts) with poor performance status
Grivas, P., Plimack, E., Balar, A.V., Castellano, D., O'Donnell, P.H., Bellmunt, J., Powles, T., Hahn, N., de Wit, R., Bajorin, D., Ellison, M.C., Frenkl, T., Keefe, S.M., Vuky, J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article